Bosh sahifaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
27,14 $
Seans yopilganidan keyin:(0,00%)0,00
27,14 $
Yopilgan:16-apr, 16:02:32 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
27,82 $
Kunlik diapazon
26,87 $ - 27,74 $
Yillik diapazon
23,42 $ - 62,58 $
Bozor kapitalizatsiyasi
1,56 mlrd USD
Oʻrtacha hajm
704,96 ming
Narx/foyda
2,33
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,73 mln | 51,06% |
Joriy xarajat | 51,70 mln | 46,43% |
Sof foyda | -96,52 mln | -0,61% |
Sof foyda marjasi | -899,56 | 33,40% |
Har bir ulushga tushum | -1,74 | -1,16% |
EBITDA | -123,67 mln | -17,92% |
Amaldagi soliq stavkasi | 8,42% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 893,71 mln | 15,03% |
Jami aktivlari | 1,66 mlrd | 77,48% |
Jami passivlari | 122,24 mln | -3,06% |
Umumiy kapital | 1,54 mlrd | — |
Tarqatilgan aksiyalar | 57,30 mln | — |
Narxi/balansdagi bahosi | 1,03 | — |
Aktivlardan daromad | -18,09% | — |
Kapitaldan daromad | -19,03% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -96,52 mln | -0,61% |
Operatsiyalardan naqd pul | -133,17 mln | -83,71% |
Sarmoyadan naqd pul | -49,16 mln | -151,47% |
Moliyadan naqd pul | 4,84 mln | 471,66% |
Naqd pulning sof oʻzgarishi | -177,48 mln | -843,48% |
Boʻsh pul | -108,06 mln | -155,48% |
Haqida
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tashkil etilgan
2008
Sayt
Xodimlar soni
487
